logo
ProjectFinanced

EXEVIR (COVID-19) (IDFF)

Sector: Manufacturing (Industrial) • Location: Belgium

Source: European Investment Bank (EIB)

The Promoter is a Belgium-based clinical stage company that develops single-domain antibody-based therapies (VHH or nanobodies). The Project supports the development of the Company's lead product, XVR012 in COVID-19, including inter alia clinical and regulatory approvals in the EU and the US, scale-up of manufacturing operations and the R&D activities for a sub-cutaneous formulation.

Status
Prospective
Sector
Manufacturing (Industrial), Hospital, Hotel, Government
Location
Belgium
Updated
19 Nov 2026
Source
European Investment Bank (EIB)

ConstructChat

Ask ConstructChat about EXEVIR (COVID-19) (IDFF)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “EXEVIR (COVID-19) (IDFF)” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Belgium. Taiyo aggregates data on it from European Investment Bank (EIB).

Participants

Sponsoring Agency

Status

Original status

financed

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The Promoter is a Belgium-based clinical stage company that develops single-domain antibody-based therapies (VHH or nanobodies). The Project supports the development of the Company's lead product, XVR012 in COVID-19, including inter alia clinical and regulatory approvals in the EU and the US, scale-up of manufacturing operations and the R&D activities for a sub-cutaneous formulation.

Original sector

Industry

Budget

Location

Country

Belgium

Source

Source reliability

High

Source

European Investment Bank (EIB)

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Hospital, Hotel, Government

Article published date

2023-05-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project